Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness of Sonu Acoustic Resonance Therapy for the Treatment of Pediatric Patients With Moderate to Severe Nasal Congestion.

NCT06773013 is registered in ClinicalTrials.gov with Third Wave Therapeutics as lead sponsor.

NCT NCT06773013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06773013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness of Sonu Acoustic Resonance Therapy for the Treatment of Pediatric Patients With Moderate to Severe Nasal Congestion.
Lead sponsor
Third Wave Therapeutics
Phase
Not applicable
Overall status
Completed
Start date
January 9, 2025
Completion date
March 30, 2025
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasal congestion and inflammations